Unlocking the potential of anti-CD33 therapy in adult and childhood acute myeloid leukemia.

Abstract:

:Acute myeloid leukemia (AML) develops when there is a block in differentiation and uncontrolled proliferation of myeloid precursors, resulting in bone marrow failure. AML is a clinically, morphologically, and genetically heterogeneous disease, and biological differences between adult and childhood AML have been identified. AML comprises 15%-20% of all children <15 years of age diagnosed with acute leukemia. Relapse occurs in up to 40% of children with AML and is the most common cause of death. Relapse arises from leukemic stem cells (LSCs) that persist after conventional chemotherapy. The treatment of AML is challenging, and new strategies to target LSCs are required. The cell surface marker CD33 has been identified as a therapeutic target, and novel anti-CD33 immunotherapies are promising new agents in the treatment of AML. This review summarizes recent developments emphasizing the genetic differences in adult and childhood AML and highlights the rationale for CD33 as a target for therapy in all age groups.

journal_name

Exp Hematol

journal_title

Experimental hematology

authors

Laing AA,Harrison CJ,Gibson BES,Keeshan K

doi

10.1016/j.exphem.2017.06.007

subject

Has Abstract

pub_date

2017-10-01 00:00:00

pages

40-50

eissn

0301-472X

issn

1873-2399

pii

S0301-472X(17)30237-0

journal_volume

54

pub_type

杂志文章,评审
  • Targeting cell-bound MUC1 on myelomonocytic, monocytic leukemias and phenotypically defined leukemic stem cells with anti-SEA module antibodies.

    abstract::Cell surface molecules aberrantly expressed or overexpressed by myeloid leukemic cells represent potential disease-specific therapeutic targets for antibodies. MUC1 is a polymorphic glycoprotein, the cleavage of which yields two unequal chains: a large extracellular α subunit containing a tandem repeat array bound in ...

    journal_title:Experimental hematology

    pub_type: 杂志文章

    doi:10.1016/j.exphem.2018.12.002

    authors: Guillaume T,Dehame V,Chevallier P,Peterlin P,Garnier A,Grégoire M,Pichinuk E,Rubinstein DB,Wreschner DH

    更新日期:2019-02-01 00:00:00

  • The use of a right atrial catheter in bone marrow transplantation for acute leukemia.

    abstract::A right atrial catheter was implanted into 15 patients undergoing bone marrow transplantation as a treatment for acute leukemia. The catheter remained in position for 79 +/- 34 days. No catheter-related septicemia was observed. It appears that this catheter is helpful in supporting bone marrow transplant recipients. ...

    journal_title:Experimental hematology

    pub_type: 杂志文章

    doi:

    authors: Blume KG,Bross KJ,Riihimaki DU,Schmidt GM

    更新日期:1978-08-01 00:00:00

  • Differential gene expression signatures of adult peripheral blood vs cord blood monocyte-derived immature and mature dendritic cells.

    abstract:OBJECTIVE:Our previous studies have demonstrated differentially expressed genetic signature patterns in adult peripheral blood (APB) monocytes (Mos) vs cord blood (CB) Mos. MATERIALS AND METHODS:In this study, we examined the differential gene expression profiles of APB vs CB immature dendritic cells (iDCs) and mature...

    journal_title:Experimental hematology

    pub_type: 杂志文章

    doi:10.1016/j.exphem.2009.07.010

    authors: Jiang H,van de Ven C,Baxi L,Satwani P,Cairo MS

    更新日期:2009-10-01 00:00:00

  • Localization of megakaryocytes in normal mice and following administration of platelet antiserum, 5-fluorouracil, or radiostrontium: evidence for the site of platelet production.

    abstract::The relative contributions of various organs to platelet production is controversial. In this study, serial histologic sections of bone marrow, spleen, liver, and lung from normal C57BL/6J mice and mice that had received three different agents which perturb normal murine thrombopoiesis (platelet antiserum, 5-fluoroura...

    journal_title:Experimental hematology

    pub_type: 杂志文章

    doi:

    authors: Davis RE,Stenberg PE,Levin J,Beckstead JH

    更新日期:1997-07-01 00:00:00

  • Transfection of interferon-gamma gene in a mouse bone marrow stromal preadipocyte cell line causes apoptotic cell death.

    abstract::It has been reported that bone marrow and serum of patients with aplastic anemia or chronic myeloproliferative disorders contain an abnormal concentration of cytokines. In the present study, we tried to isolate mouse bone marrow stromal cell lines that were stably transformed with a variety of cytokine genes and that ...

    journal_title:Experimental hematology

    pub_type: 杂志文章

    doi:

    authors: Nakano T,Otsuka T,Ogo T,Niiro H,Kuga S,Zipori D,Furukawa Y,Niho Y

    更新日期:1993-10-01 00:00:00

  • The BMP pathway: A unique tool to decode the origin and progression of leukemia.

    abstract::The microenvironment (niche) governs the fate of stem cells (SCs) by balancing self-renewal and differentiation. Increasing evidence indicates that the tumor niche plays an active role in cancer, but its important properties for tumor initiation progression and resistance remain to be identified. Clinical data show th...

    journal_title:Experimental hematology

    pub_type: 杂志文章,评审

    doi:10.1016/j.exphem.2018.02.005

    authors: Zylbersztejn F,Flores-Violante M,Voeltzel T,Nicolini FE,Lefort S,Maguer-Satta V

    更新日期:2018-05-01 00:00:00

  • Cell biological effects of total body irradiation on growth and differentiation of acute myelogenous leukemia cells compared to normal bone marrow.

    abstract::Radiation therapy is used as total body treatment in preparation of the acute myelogenous leukemia (AML) patient for bone marrow transplantation. Many AML patients will have residual leukemia cells at the time of total body irradiation (TBI). In the present study, the effect of TBI on leukemic myeloid cells was compar...

    journal_title:Experimental hematology

    pub_type: 杂志文章

    doi:

    authors: Greenberger JS,Weichselbaum RR,Botnick LE,Sakakeeny M,Moloney WC

    更新日期:1979-01-01 00:00:00

  • Immunologic recovery after hematopoietic cell transplantation with nonmyeloablative conditioning.

    abstract:OBJECTIVE:We studied immune reconstitution in 51 recipients of HLA-identical hematopoietic cellular transplant (HCT) after nonmyeloablative conditioning compared to a reference group of 67 recipients after myeloablative conditioning. METHODS:Nonmyeloablative conditioning consisted of 2 Gy total-body irradiation+/-flud...

    journal_title:Experimental hematology

    pub_type: 杂志文章

    doi:10.1016/s0301-472x(03)00201-7

    authors: Maris M,Boeckh M,Storer B,Dawson M,White K,Keng M,Sandmaier B,Maloney D,Storb R,Storek J

    更新日期:2003-10-01 00:00:00

  • Effective treatment against severe graft-versus-host disease with allele-specific anti-HLA monoclonal antibody in a humanized mouse model.

    abstract::Graft-versus-host disease (GVHD), mediated by donor-derived alloreactive T cells, is a major cause of nonrelapse mortality in allogeneic hematopoietic stem cell transplantation. Its therapy is not well-defined. We established allele-specific anti-human leukocyte antigen (HLA) monoclonal antibodies (ASHmAbs) that speci...

    journal_title:Experimental hematology

    pub_type: 杂志文章

    doi:10.1016/j.exphem.2014.10.008

    authors: Nakauchi Y,Yamazaki S,Napier SC,Usui J,Ota Y,Takahashi S,Watanabe N,Nakauchi H

    更新日期:2015-02-01 00:00:00

  • Characterization of marrow stromal (fibroblastoid) cells and their association with erythropoiesis.

    abstract::Our previous studies suggested that a defect in the hemopoietic microenvironment of bone marrow occurred in the anemia of chronic inflammatory disease. We examined the in vivo hemopoietic and marrow stromal cell (MSC) response of shielded marrow to 5000 rad leg-irradiation (5000 rad LI), the in vitro growth of BFUE, C...

    journal_title:Experimental hematology

    pub_type: 杂志文章

    doi:

    authors: Werts ED,DeGowin RL,Knapp SK,Gibson DP

    更新日期:1980-04-01 00:00:00

  • Improved assessment of bioactive erythropoietin in human sera using a modified tritiated-thymidine-incorporation assay.

    abstract::The reproducibility and utility of an in vitro bioassay for erythropoietin were evaluated, and modifications, including the use of frozen target cells, were made. The assay, based on 3H-thymidine incorporation into phenylhydrazine-treated mouse spleen cells, showed a dose-response curve from 0.2 to 20 mU of sheep plas...

    journal_title:Experimental hematology

    pub_type: 杂志文章

    doi:

    authors: Paul P,Rothmann SA,Zydiak L,Beck GJ

    更新日期:1987-05-01 00:00:00

  • Stochastic model of human granulocyte-macrophage progenitor cell proliferation and differentiation. II. Validation of the model.

    abstract::In the accompanying paper we constructed a model for the proliferation and differentiation of granulocyte-macrophage progenitor cells in response to the specific proliferation/differentiation stimulus granulocyte-macrophage colony-stimulating activity (gm-CSA). Here we have tested the model without altering the model ...

    journal_title:Experimental hematology

    pub_type: 杂志文章

    doi:

    authors: Leaning MS,Francis GE

    更新日期:1985-02-01 00:00:00

  • Indomethacin augments granulocyte-macrophage colony-stimulating factor-induced hematopoiesis following 5-FU treatment.

    abstract::We have previously reported that granulocyte-macrophage colony-stimulating factor (GM-CSF) given after the administration of 5-fluorouracil (5-FU) results in augmented hematopoietic recovery as evidenced by increased white blood cell and neutrophil counts. Mice receiving GM-CSF following 5-FU administration were obser...

    journal_title:Experimental hematology

    pub_type: 杂志文章

    doi:

    authors: O'Reilly M,Gamelli RL

    更新日期:1990-10-01 00:00:00

  • Identification of Ponatinib as a potent inhibitor of growth, migration, and activation of neoplastic eosinophils carrying FIP1L1-PDGFRA.

    abstract::In chronic eosinophilic leukemia, the transforming oncoprotein FIP1L1-PDGFRA is a major target of therapy. In most patients, the tyrosine kinase inhibitor (TKI) imatinib induces complete remission. For patients who are intolerant or resistant, novel TKIs have been proposed. We examined the in vitro effects of 14 kinas...

    journal_title:Experimental hematology

    pub_type: 临床试验,杂志文章

    doi:10.1016/j.exphem.2013.12.007

    authors: Sadovnik I,Lierman E,Peter B,Herrmann H,Suppan V,Stefanzl G,Haas O,Lion T,Pickl W,Cools J,Vandenberghe P,Valent P

    更新日期:2014-04-01 00:00:00

  • Differentiation of human myeloblastic leukemia ML-1 cells into macrophages by staurosporine, an inhibitor of protein kinase activities.

    abstract::Protein kinase activities are involved in cellular proliferation and differentiation, and inhibitors of these activities are useful for studying the mechanisms of induction of differentiation. We found that staurosporine, an inhibitor of protein kinase activities, induced morphological differentiation of human myelobl...

    journal_title:Experimental hematology

    pub_type: 杂志文章

    doi:

    authors: Makishima M,Honma Y,Hozumi M,Sampi K,Motoyoshi K,Nagata N,Hattori M

    更新日期:1993-07-01 00:00:00

  • A new interferon, limitin, displays equivalent immunomodulatory and antitumor activities without myelosuppressive properties as compared with interferon-alpha.

    abstract:OBJECTIVE:Limitin is a new member of type I interferon (IFN) identified with an expression cloning based on the growth suppression of a myelomonocytic leukemia cell line WEHI3. Although limitin uses the IFN-alpha/beta receptor, its signal transduction pathways to express the antiviral effects are different from those o...

    journal_title:Experimental hematology

    pub_type: 杂志文章

    doi:10.1016/j.exphem.2004.06.008

    authors: Kawamoto S,Oritani K,Asakura E,Ishikawa J,Koyama M,Miyano K,Iwamoto M,Yasuda S,Nakakubo H,Hirayama F,Ishida N,Ujiie H,Masaie H,Tomiyama Y

    更新日期:2004-09-01 00:00:00

  • Long-term culture of primary human lymphoblastic leukemia cells in the absence of serum or hematopoietic growth factors.

    abstract:OBJECTIVE:B-lineage acute lymphoblastic leukemia (ALL) and chronic myeloid leukemia in lymphatic blastic phase in adults have poor prognoses despite intensive chemotherapy. Novel targeted treatment modalities emerge, but their evaluation requires relevant in vitro models of lymphoblastic leukemia. Presently available c...

    journal_title:Experimental hematology

    pub_type: 杂志文章

    doi:10.1016/j.exphem.2008.11.002

    authors: Nijmeijer BA,Szuhai K,Goselink HM,van Schie ML,van der Burg M,de Jong D,Marijt EW,Ottmann OG,Willemze R,Falkenburg JH

    更新日期:2009-03-01 00:00:00

  • Comparative analysis of naïve and memory CD4+ and CD8+ T-cell subsets in bone marrow and G-CSF-mobilized peripheral blood stem cell allografts: impact of donor characteristics.

    abstract:OBJECTIVE:Donor T cells expressing lymph node homing receptors are the foremost initiators of acute graft-vs-host disease (aGVHD), and a high proportion of CD4(+)CCR7(+) T cells in human leukocyte antigen-matched allografts has been shown to confer a high risk of aGVHD without interfering in other outcomes. METHODS:Na...

    journal_title:Experimental hematology

    pub_type: 临床试验,杂志文章

    doi:10.1016/j.exphem.2007.03.006

    authors: Yakoub-Agha I,Saule P,Depil S,Grutzmacher C,Boulanger F,Magro L,Jouet JP,Dessaint JP,Labalette M

    更新日期:2007-06-01 00:00:00

  • Development of monoclonal antibodies for analyzing immune and hematopoietic systems of common marmoset.

    abstract:OBJECTIVE:Common marmosets are considered experimental animals of primates useful for medical research. We developed several monoclonal antibodies (mAbs) directed to CD molecules to gain initial insight into the immune and hematopoietic systems of this organism, and analyzed the basic cellularity and characters of marm...

    journal_title:Experimental hematology

    pub_type: 杂志文章

    doi:10.1016/j.exphem.2009.08.003

    authors: Kametani Y,Suzuki D,Kohu K,Satake M,Suemizu H,Sasaki E,Ito T,Tamaoki N,Mizushima T,Ozawa M,Tani K,Kito M,Arai H,Koyanagi A,Yagita H,Habu S

    更新日期:2009-11-01 00:00:00

  • Specificity of hemin action in vivo at early stages of hematopoietic cell differentiation.

    abstract::The effects of a single injection of hemin on murine marrow BFU-E and CFU-S were assessed to determine whether hemin is as effective in augmenting primitive (day 7) BFU-E levels in situ as it is in vitro and to assess hemin's action on transplantable pluripotent stem cells (CFU-S). The results show that hemin exerts a...

    journal_title:Experimental hematology

    pub_type: 杂志文章

    doi:

    authors: Monette FC,Holden SA,Sheehy MJ,Matzinger EA

    更新日期:1984-11-01 00:00:00

  • Characteristics of megakaryocyte colony formation in normal individuals and in primary thrombocythemia: studies using an optimal cloning system.

    abstract::Colony formation by megakaryocyte (MK) progenitors was studied in 36 normal individuals and in 26 patients with primary thrombocythemia (PT) using an improved plasma clot cloning system. MK colonies were identified by immunoperoxidase staining using a monoclonal antibody against human platelet glycoprotein IIb/IIIa co...

    journal_title:Experimental hematology

    pub_type: 杂志文章

    doi:

    authors: Han ZC,Briere J,Abgrall JF,Sensebe L,Parent D,Guern G

    更新日期:1989-01-01 00:00:00

  • Granulocyte transfusions in recovery of neutropenic rats from induced E. coli toxicemia.

    abstract::Rats made transiently neutropenic by intra-arterial administration of vinblastine (3 mg/kg) and infected with E. coli (6.02+/-0.45 X 10(8), per animal) have a mortality rate of 90% within 48 h post infection. Multiple transfusions of large numbers of granulocytes (harvested from Deca-Durabolin treated donor rats) prot...

    journal_title:Experimental hematology

    pub_type: 杂志文章

    doi:

    authors: Popovic V,Schaffer R,Popovic P

    更新日期:1977-05-01 00:00:00

  • Targeted gene correction of RUNX1 in induced pluripotent stem cells derived from familial platelet disorder with propensity to myeloid malignancy restores normal megakaryopoiesis.

    abstract::Familial platelet disorder with propensity to acute myeloid leukemia (FPD/AML) is an autosomal dominant disease associated with a germline mutation in the RUNX1 gene and is characterized by thrombocytopenia and an increased risk of developing myeloid malignancies. We generated induced pluripotent stem cells (iPSCs) fr...

    journal_title:Experimental hematology

    pub_type: 杂志文章

    doi:10.1016/j.exphem.2015.05.004

    authors: Iizuka H,Kagoya Y,Kataoka K,Yoshimi A,Miyauchi M,Taoka K,Kumano K,Yamamoto T,Hotta A,Arai S,Kurokawa M

    更新日期:2015-10-01 00:00:00

  • Exogenous iron increases hemoglobin in beta-thalassemic mice.

    abstract:OBJECTIVE:Beta-thalassemia results from beta-globin gene mutations that lead to ineffective erythropoiesis, shortened red cell survival, and anemia. Patients with beta-thalassemia develop iron overload, despite which, hepcidin levels are low. This suggests that hepcidin regulation in beta-thalassemia is more sensitive ...

    journal_title:Experimental hematology

    pub_type: 杂志文章

    doi:10.1016/j.exphem.2008.10.004

    authors: Ginzburg YZ,Rybicki AC,Suzuka SM,Hall CB,Breuer W,Cabantchik ZI,Bouhassira EE,Fabry ME,Nagel RL

    更新日期:2009-02-01 00:00:00

  • X-linked thrombocytopenia caused by a mutation in the Wiskott-Aldrich syndrome (WAS) gene that disrupts interaction with the WAS protein (WASP)-interacting protein (WIP).

    abstract:OBJECTIVE:We studied two adult brothers with severe congenital thrombocytopenia in order to determine the genetic etiology of their inherited disorder. Despite the absence of eczema or immunodeficiency, a mutation of the Wiskott-Aldrich syndrome (WAS) gene was suspected because of the presence of microthrombocytes. MA...

    journal_title:Experimental hematology

    pub_type: 杂志文章

    doi:10.1016/s0301-472x(02)01023-8

    authors: Luthi JN,Gandhi MJ,Drachman JG

    更新日期:2003-02-01 00:00:00

  • Heterozygous kit mutants with little or no apparent anemia exhibit large defects in overall hematopoietic stem cell function.

    abstract:OBJECTIVE:The evolutionarily conserved Kit receptor is vital for function of hematopoietic stem cells (HSC). Kit(W-41) (W-41) and Kit(W-42) (W-42) are single residue changes in the KIT intracellular phosphotransferase domain, while Kit(W-v) (W-v) is a single residue change in the ATP binding domain. This study tests ho...

    journal_title:Experimental hematology

    pub_type: 杂志文章

    doi:10.1016/j.exphem.2006.10.001

    authors: Sharma Y,Astle CM,Harrison DE

    更新日期:2007-02-01 00:00:00

  • Clonal proliferation in vitro of individual murine and human hemopoietic cells after fluorescence-activated cell sorting.

    abstract::A modification of the fluorescence-activated cell sorter (FACS) was used to rapidly and reliably study the clonal proliferation of single hemopoietic cells. Murine FDC-P1 and human cord blood progenitor cells were examined for their ability to proliferate from single cells in 96-well microtiter plates containing agar ...

    journal_title:Experimental hematology

    pub_type: 杂志文章

    doi:

    authors: Kannourakis G,Johnson GR,Battye F

    更新日期:1988-06-01 00:00:00

  • Monoclonal antibody 9C4 recognizes epithelial cellular adhesion molecule, a cell surface antigen expressed in early steps of erythropoiesis.

    abstract:OBJECTIVE:Monoclonal antibody (mAb) 9C4 detects a surface antigen expressed on immature erythroid progenitor cells and epithelial tumor cell lines. The aim of this study was to identify the recognized surface antigen and to analyze a potential role of this molecule in early steps of erythropoiesis. MATERIALS AND METHO...

    journal_title:Experimental hematology

    pub_type: 杂志文章

    doi:10.1016/s0301-472x(02)00798-1

    authors: Lammers R,Giesert C,Grünebach F,Marxer A,Vogel W,Bühring HJ

    更新日期:2002-06-01 00:00:00

  • Poly(A)-poly(U) induces circulating colony-stimulating activity resulting from interactions between endogeneous interleukin 6 and serum components.

    abstract::The immunostimulant poly(A)-poly(U) induces a rapid enhancement of circulating colony-stimulating activity (CSA) in normal mice, culminating 2 h after i.v. injection. A dose of 200 micrograms per mouse is sufficient for a maximal effect. The colonies formed in response to sera from poly(A)-poly(U)-injected mice are ma...

    journal_title:Experimental hematology

    pub_type: 杂志文章

    doi:

    authors: Dy M,Arnould A,Schneider E

    更新日期:1991-05-01 00:00:00

  • Biological implications of clonal hematopoiesis.

    abstract::Adult hematological malignancies, such as acute myeloid leukemia, are thought to arise through the gradual acquisition of oncogenic mutations within long-lived hematopoietic stem cells (HSCs). Genomic analysis of peripheral blood DNA has recently identified leukemia-associated genetic mutations within otherwise health...

    journal_title:Experimental hematology

    pub_type: 杂志文章,评审

    doi:10.1016/j.exphem.2019.08.004

    authors: Luis TC,Wilkinson AC,Beerman I,Jaiswal S,Shlush LI

    更新日期:2019-09-01 00:00:00